Bayer AG NA
Sentinellis health
4.2/10
Moderate concerns
Market capitalisation
EUR 37.8B
Revenue (TTM)
EUR 45.6B
§ I · AI Analysis
The brief
Bayer makes prescription medicines for heart disease, women's health, cancer, and blood disorders; sells consumer brands like Midol and Aspirin; and provides seeds, pesticides, and digital farming tools to agriculture customers worldwide [Yahoo Finance]. The Crop Science division is the largest profit contributor, generating nearly half of total revenue [Simply Wall St].
Bayer is a 161-year-old German life sciences giant operating three major divisions: prescription drugs (Pharmaceuticals), over-the-counter health products (Consumer Health), and agricultural seeds and crop chemicals (Crop Science) [Yahoo Finance]. The company currently reports a €2.2 billion net loss on €45.6 billion in revenue, but recent news signals potential recovery through two FDA priority-review drugs in stroke prevention and lung cancer [Yahoo Finance]. Bayer also faces ongoing environmental liabilities, including a recent $133 million settlement for PCB contamination cleanup [Seeking Alpha].
Bayer is currently unprofitable with moderate debt levels, but maintains strong gross margins and positive free cash flow [Yahoo Finance].
§ II · Recent news
What moved
6 stories · ranked by relevance
- macro2026-05-20
BAYRY or RHHBY: Which Is the Better Value Stock Right Now?
Zacks
- macro2026-05-20
Should FDA Priority Review for HYRNUO’s First-Line Lung Cancer Use Require Action From Bayer (XTRA:BAYN) Investors?
Yahoo Finance
- macro2026-05-19
Bayer Gets FDA Priority Review for Asundexian NDA in Stroke Prevention
Yahoo Finance
- macro2026-05-19
Bayer Granted Priority Review by U.S. FDA for Asundexian in Patients After a Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack
Yahoo Finance
- macro2026-05-19
FDA Grants Priority Tag to Bayer's Oncology Drug for First-Line NSCLC
Yahoo Finance
- macro2026-05-17
Assessing Bayer (XTRA:BAYN) Valuation After Mixed Share Performance And Profit Recovery Hopes
Simply Wall St
Premium · Free with any account
Risk Analysis
Opportunities
Full Financials
Executive Team
Unlock the full Bayer AG NA analysis
Create a free account to access the complete AI-generated report with inline citations.
- Risks, opportunities, and red flags with sources
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
§ III · Related
You might also read
Same sector · Healthcare or comparable health
Want this for your watchlist?